{"ticker": {"uuid": "50b808a8-952d-4817-9c74-13ddfe46d1f1", "symbol": "VERX", "name": "Vertex", "exchange": "NASDAQ", "country": "US", "sector": "Technology", "industry": "Software - Application"}, "articles": [{"title": "Can AI-Driven Tax Tech Competition Reshape Vertex\u2019s (VERX) Regulation-Focused Growth Narrative?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-22T09:40:54+00:00", "published_display": "22 Jul 2026 09:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. Stock 12\u2011Month Price Target Cut to $17.69, Implies 37% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQNnduZ2RQNDlGMVhDU0wtU0xrRU9yRWlYSEpnbnFPUW55NTJabExtSzM2X2haaVBGR0pxQThlYmEycXg5eWExM0JWQzEtNFRKWTRVVGZhblBxeVFudjJ4Q2NVOWlabzdhdGVmeWVhRjdkN1FyelJvaXUtbmRqZWp1YUpnZi1aTHJ1MFh2ZWlHV1Zla0RrSExmQTZ6OXhiR2xqODJSeEwxM3ZZcEdmLUxRQ3RKa3ZWUDQtTlJVVkdlQXByS0pmOFRiNzQ3NA?oc=5", "source_name": "TradingView", "published_at": "2026-07-21T22:20:12+00:00", "published_display": "21 Jul 2026 22:20", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ:VERX) Shares Gap Down - Time to Sell?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOeDlSVHROZFNUWWhQd3RFQk5zTjdfWVZkbm1hQ09JZmZCRnhmUDgzR2tnWHQ0bmZiTzJCQ2hadzdlZ0M5NVJQR2JIQy05cm5LS3E5ZmZRaTFPNlgyVFBDWGV3TURSOE9YYjF6UlpMNTJ4UUg3WGItaE5lYjRISjJBWE5YUkNHWmJMcjBkT0dtaFBaVEJGa2dFOGl4Z2JlMHhYWEE?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-21T15:55:01+00:00", "published_display": "21 Jul 2026 15:55", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Facing Uncertain Growth Path Amid AI Fears, Morgan Stanley Says", "summary": "", "url": "https://finance.yahoo.com/technology/ai/articles/vertex-facing-uncertain-growth-path-150628432.html", "source_name": "MT Newswires", "published_at": "2026-07-21T15:06:28+00:00", "published_display": "21 Jul 2026 15:06", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Correction: Morgan Stanley Downgrades Vertex to Equalweight From Overweight Adjusts PT to $15 From $19", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/correction-morgan-stanley-downgrades-vertex-102415096.html", "source_name": "MT Newswires", "published_at": "2026-07-21T10:24:15+00:00", "published_display": "21 Jul 2026 10:24", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley Downgrades Vertex to Equalweight From Overweight, Cuts Price Target to $15 From $19", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/morgan-stanley-downgrades-vertex-equalweight-102111462.html", "source_name": "MT Newswires", "published_at": "2026-07-21T10:21:11+00:00", "published_display": "21 Jul 2026 10:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma stock trades near record levels as cystic fibrosis franchise drives earnings growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNZnhfa2JWdGZ3RWR3SWlWNGpwLTVvZS02V2VkbWhuS183b2w3T2xqTlo2cTE5WEV5R0VpdHlfMWk3MEtjWU1DU05nTVlkdjdId19rbENMblUtZ3FXUFh0amd5MlozU2VyOWdabVZYdC12Y2lXU3h2VkZXRG9WUW9hQUZWendYd25qNUxxVHBRU2xldUxkQU9zMm94cjktOVhfLTN6aXA3VmRhSnJ5cWJLT2dxUVR0LThGdnJMXzQ5U3pSY3dydjFKeHlDcWpfZw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T02:41:41+00:00", "published_display": "21 Jul 2026 02:41", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal Plans", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-21T00:47:15+00:00", "published_display": "21 Jul 2026 00:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma stock trades near highs as cystic fibrosis portfolio drives double digit revenue growt", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOTzhSTHQzWjB4NmVtaXFVQnBkWmgtLVMzUjNYSVRsR3I3U1RVamZlMTFTSXg5T1JURUpOX1RBT0NPMk9qaVBNMVB3c2laSm5fLUUxZEhmOFcwYmFpR1pFTU9oR0VWdFo0cGcyc1pWbGV3LXhhYnp5UUQ4TUMxX0RzcjFfQkg2VmREN1Jfak5CMHplQU5faXFwemdKa3RpdjRoZk5ZVmtxczdWcENKcVVpcVJvRUZ6c3V1bVdfdGpBdjF2UFlMcjYzRWNqWUw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-20T14:14:50+00:00", "published_display": "20 Jul 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex schedules 5 p.m. call on Aug. 3 to discuss results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQVWY0eGdKTmFQNGNmc3hZY2xZdDlzUEdZSEhVMlpaUXBhQlQzTEJ3MUhBcDVKRHdvZGE3OExsR0h4dERCRGZRb2dpY1BNOGxVb3c5NTZQTmNJZl8wb3hNcjZ3U25kSlNVZGtmdUJfSDJVOXBLYXRLWk5XUVBSYWNfYmgxVlRsSXBZVjV3Y1RTSEc4SHBNMDNBT2pQeXdNenZ3Yl9uVzc4RzNZbk1QTUFiYmhwZFh4ZzQtVERWblVn?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:30:00+00:00", "published_display": "14 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to Announce Second Quarter 2026 Financial Results on Monday, August 3, 2026", "summary": "Vertex, Inc. (NASDAQ:VERX) announced that it will release its second quarter 2026 financial results after market close on Monday, August 3, 2026. A conference call to discuss these results will be held at 5:00 p.m. Eastern Time on the same day. Investors can register for the live", "url": "https://www.sahmcapital.com/news/content/vertex-to-announce-second-quarter-2026-financial-results-on-monday-august-3-2026-2026-07-14", "source_name": "Sahm", "published_at": "2026-07-14T12:40:53", "published_display": "14 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Vertex, Inc. Class A \u2013 LS:A2P93F", "summary": "This article focuses on the \"Enterprise value to EBIT forward\" metric for Vertex, Inc. Class A, identified by the stock symbol A2P93F on the Lang & Schwarz Tradecenter. The piece is primarily a financial data point from TradingView, indicating a specific valuation ratio for the c", "url": "https://www.tradingview.com/symbols/LS-A2P93F/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-12T11:10:47", "published_display": "12 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Vertex, Inc. Class A \u2013 LSX:A2P93F", "summary": "This article displays the enterprise value to EBIT forward for Vertex, Inc. Class A (LSX:A2P93F) on TradingView. It provides a brief financial metric for the company, accessible through the platform's various financial tools and data services.", "url": "https://www.tradingview.com/symbols/LSX-A2P93F/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T10:10:09", "published_display": "11 Jul 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Inc (VERX) Shares Fall 3.2% -- What GF Score of 61 Tells Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU0NaM0tiUm5Fbk5YVzFEcXdLaXV2bGR2R1NVb3JzR25yMm1yVTRqMkVHd2J4NTI0dXN3QmsyTmxlME1FRjl3TFJNSmhhaHhJVVFCNTZONXF5MGpTR3A0QnVKeW1PTVBzNGdFVENPd1c1Ty1VQWVMY3d6VkY0em5QSENvRVJ6S2tDc2pMRlR1SzhRci1qTXY1bnpUbGtwUnp2SXd6UFpVX0RCTzJ1d3BpdDU1S3JLajRs?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T22:58:15+00:00", "published_display": "10 Jul 2026 22:58", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Understanding Momentum Shifts in (VERX)", "summary": "This article provides an analysis of Vertex Inc. (VERX) stock, highlighting strong near and mid-term sentiment but a weak long-term outlook. It presents AI-generated trading strategies for different risk profiles, including position trading, momentum breakout, and risk hedging, a", "url": "https://news.stocktradersdaily.com/news_release/1/Understanding_Momentum_Shifts_in_VERX_071026040401_1783713841.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-10T16:04:00", "published_display": "10 Jul 2026 16:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TD Cowen Rates Vertex (VERX) A Buy; Sees Sentiment Improving On Execution", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOc0U1NEgxemRleW1SMEFIVy1KX3lmd3ZfZTJYMHBKN3ZoR0xPcHY0d3JZY2x5WGZFZmdnd2Vsak9LdEVhOVNHZVFSXzVGNFJYRkNGZ2tLdnhRTXJMaE1IRk43YkJadHBpS0E1OHRwQ2RJTm1scG5fcnV4Y0R3VUN3S3FfclMxYTJsN3hWSmtZdDF2UzBjbXc?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Vertex Stock Is Rising Today", "summary": "", "url": "https://finance.yahoo.com/m/4c378eb1-24dd-349f-ae04-0604d05f7b6c/why-vertex-stock-is-rising.html", "source_name": "Motley Fool", "published_at": "2026-06-29T16:21:15+00:00", "published_display": "29 Jun 2026 16:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TD Cowen Initiates Vertex at Buy With $14 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/td-cowen-initiates-vertex-buy-105647738.html", "source_name": "MT Newswires", "published_at": "2026-06-29T10:56:47+00:00", "published_display": "29 Jun 2026 10:56", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma enters Russell 1000 value, shares reflect mixed benchmark shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPTzV2bGgyQlphM1F0NU9ieGJrTENmWkV6UVRYTEp1djd2MHpfdFRscUxkamtMY1lHRk56VHZSRnd4Tnc1dEVTV0M0aFJpeFZXNnJhNDVVTkJ6YW5QNy1raGZUU0dxaWhWdWY5SmRwSmhNYS1ENmlmTVJZMTdydnQ4UF90QlFNaERQS25TUE9YcnktM2xLN0dDVWtQQ0lKQ1FmamxvYnlOWEhQdWtrSlNDYzU0cktiRE5Zb21HMzVKdWtGWDl2bjFrMg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-29T08:39:04+00:00", "published_display": "29 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. Class A Actuals & Estimates (NASDAQ:VERX)", "summary": "This article provides current financial data and analyst estimates for Vertex, Inc. (VERX), a company traded on NASDAQ. It covers stock performance, price targets, earnings, revenue, market capitalization, and volatility, along with answers to frequently asked questions about the", "url": "https://www.tradingview.com/symbols/NASDAQ-VERX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T13:09:42", "published_display": "26 Jun 2026 13:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Vertex, Inc. Class A \u2013 FWB:56X", "summary": "This page from TradingView provides financial information for Vertex, Inc. Class A (FWB:56X) on the Frankfurt Stock Exchange, specifically focusing on its Price to Earnings Forward metric. The content highlights the stock's overview, financials, news, and community discussions. I", "url": "https://www.tradingview.com/symbols/FWB-56X/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T00:41:37", "published_display": "26 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. Class A Actuals & Estimates (MUN:56X)", "summary": "This article provides actuals and estimates for Vertex, Inc. Class A (MUN:56X), detailing its financial performance, analyst forecasts, and key company data. It includes information on past earnings, revenue, net income, and upcoming earnings reports, along with historical stock ", "url": "https://www.tradingview.com/symbols/MUN-56X/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T23:41:37", "published_display": "25 Jun 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma Stock (US92532F1003): Analyst sentiment and ownership moves keep VRTX in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPbVZmZ1E1QlA2bS1lSXZFWVh0S0VYblN5d3FqWFpfcDZqbERuSlpYY0M1aWdfcU9OenZCb0dZT25kSHA5bXBWUkNFYno3aHRrdlNGRF9GN3pKcTRsTzZ1REdGT3ZKNEFMVHp2UUNadjUzX1ZYQmpBM252cEs2cTBZMkJsMzBLM1VMbjY0VldTd05BNnFzZlNZYVVQSWZSdjB3ZWVjOEM3NThtSTFOS2tVUUhjYXJzWllfSW9Wc2Y1WDAyOWItNGRsZg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) director Philip Saunders receives 15,638 restricted shares in equity grant", "summary": "Vertex, Inc. director Philip Seth Saunders received an equity grant of 15,638 shares of Class A Common Stock as restricted stock, with no cash purchase price. This grant increases his direct holdings to 50,606 shares. The restricted shares will vest on the earlier of the day imme", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-f969999a3bcf.html", "source_name": "Stock Titan", "published_at": "2026-06-13T12:39:12", "published_display": "13 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) director granted 15,638 restricted shares", "summary": "Vertex, Inc. director Gayton Bradley M was granted 15,638 restricted shares of Class A Common Stock at no cash cost per share, increasing his direct holdings to 68,500 shares. The restricted stock award vests on the earlier of the day before the company's next annual stockholder ", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-b1299e59442d.html", "source_name": "Stock Titan", "published_at": "2026-06-13T12:09:16", "published_display": "13 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) director granted 15,638 shares of restricted stock", "summary": "Vertex, Inc. director John Richard Stamm was granted 15,638 shares of Class A Common Stock as restricted stock, which is considered equity compensation. These shares, valued at $0.00 per share for the grant, will vest on the earlier of the day before Vertex\u2019s next annual stockhol", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-3ff8acf236f4.html", "source_name": "Stock Titan", "published_at": "2026-06-13T12:09:16", "published_display": "13 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Eric C. Andersen awarded 15,638 Vertex (VERX) restricted shares", "summary": "Vertex, Inc. director Eric C. Andersen was granted 15,638 shares of Class A common stock as restricted stock, with no cash cost. This award will vest on the earlier of the day before the next annual stockholders\u2019 meeting or June 10, 2027. Following this grant, Andersen directly h", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-affc1a87611c.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:40", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) director Westphal awarded 15,638 restricted shares", "summary": "Vertex, Inc. director and ten percent owner Amanda Westphal was awarded 15,638 restricted shares of Class A Common Stock at no purchase price. These shares will vest on the earlier of the day before the next annual stockholder meeting or June 10, 2027. Following this grant, Westp", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-48b700e1c30d.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:40", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) director granted 15,638 restricted shares, total holdings now 20,965", "summary": "Vertex, Inc. director Mark J. Mendola was granted 15,638 restricted shares of Class A Common Stock as a compensation-related award, bringing his total direct holdings to 20,965 shares. The shares were awarded at no cash cost and will vest on the earlier of the day before the comp", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-a7ce43bc6968.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:40", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) director DeStefano granted 15,638 restricted Class A shares", "summary": "Vertex, Inc. director David DeStefano was granted 15,638 Class A Common Stock shares as restricted stock, with a stated price of $0.00 per share. This award is compensation-related and will vest on the earlier of the next annual stockholders' meeting or June 10, 2027. Following t", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-6adb7bf35c2e.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:40", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VERX SEC Filings - Vertex, Inc. 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive overview of Vertex, Inc. (VERX) SEC filings, including 10-K, 10-Q, and 8-K reports, as well as insider trading forms. It highlights recent filings detailing BlackRock's stake in Vertex, credit agreement amendments for shareholder returns, a CEO ", "url": "https://www.stocktitan.net/sec-filings/VERX/page-5.html", "source_name": "Stock Titan", "published_at": "2026-06-12T18:38:40", "published_display": "12 Jun 2026 18:38", "sentiment": "positive", "sentiment_pct": 60, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VERX Stock Price, Quote & Chart | VERTEX INC - CLASS A (NASDAQ:VERX)", "summary": "This article provides an in-depth financial overview of VERTEX INC - CLASS A (NASDAQ:VERX), including its current stock price, historical performance, and key financial metrics. It highlights the company's valuation, growth, profitability, and technical and fundamental ratings. T", "url": "https://www.chartmill.com/stock/quote/VERX/profile", "source_name": "ChartMill", "published_at": "2026-06-05T21:40:11", "published_display": "05 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. (VERX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOb0FCUExTdlhQSWNGdHhHcWZ2VXBNUWgzYi1za1d4a0NsVFFwUzRpRVBoUDJxRXo5UkNvbmpRN0VMYlpWSnNWdmd1R05NbXdzWFYybEdkX2VZYVRMTEFvNnN5QUhEOFFrVDhQTG50ejZ4SGN4a1owQzhPdVhaREpPNHFNZ2paMXNoNlUyUWx6czV4SzlHSWQwTlBoc1RuQzIzTE9JVjFVRjgzaGxDNTlyeDN3b01VNUxNem05aFZZZlZNaDc4eGJj?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex director David DeStefano sells $82,365 in class A common stock.", "summary": "Vertex director David DeStefano sold 6,460 shares of Class A common stock worth $82,365 on May 28, 2026, selling at $12.75 per share, even though the stock has since risen. The shares were held indirectly through family trusts for his children. Despite this sale, Vertex Inc. rece", "url": "https://au.investing.com/news/insider-trading-news/vertex-director-david-destefano-sells-82365-in-class-a-common-stock-93CH-4465842", "source_name": "Investing.com Australia", "published_at": "2026-06-01T22:09:41", "published_display": "01 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) director\u2019s family trusts sell 6,460 shares, large stake remains", "summary": "Vertex Inc. director David DeStefano's family trusts sold 6,460 Class A Common Stock shares at $12.75 each, as reported in a Form 4 filing. Following the sale, the family trusts retained 197,572 shares, and DeStefano directly holds a substantial 1,255,517 Class A shares, indicati", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-e9512b95889c.html", "source_name": "Stock Titan", "published_at": "2026-06-01T20:40:49", "published_display": "01 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) Is Up 11.3% After Brinta Deal And AI-Focused Cost Cuts Reshape Tax Strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPd0JMcnZHYVd3UC1EOUpaYjNzR0NsX3FwUEhMZTR3NFRldzNWNkZ2MDdiTXZGRkdaT1pvSElTNzJxLWNRMEh1dDQxcDRXemkxck5mMWlEQmZ6RUE0YTR3aEtaSUNBQlhNWmhUX3cySmd4ZmJFMHl5Tks4THNHdDE2cnNxQWpRamJLNmN1SnItaGtlQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals (VRTX) Offering Opportunity After Recent Pipeline Headlines And DCF Valuation Gap", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(VERX) Movement Within Algorithmic Entry Frameworks", "summary": "This article provides an algorithmic analysis of Vertex Inc. Class A Common Stock (NASDAQ: VERX), highlighting a neutral sentiment in shorter horizons but maintaining a weak long-term bias. It outlines three distinct AI-generated trading strategies\u2014Position Trading, Momentum Brea", "url": "https://news.stocktradersdaily.com/news_release/1/VERX_Movement_Within_Algorithmic_Entry_Frameworks_052726110601_1779894361.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-27T11:06:00", "published_display": "27 May 2026 11:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. - Class A Common Stock (NQ: VERX", "summary": "This article provides a collection of recent news headlines and press releases concerning Vertex, Inc. (NASDAQ: VERX). It covers financial results announcements, tax rate reports, and various analyst and market commentary on the company's stock performance and industry position. ", "url": "https://markets.financialcontent.com/stocks/quote/news?CurrentPage=6&Symbol=NQ%3AVERX", "source_name": "FinancialContent", "published_at": "2026-05-14T13:09:52", "published_display": "14 May 2026 13:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley discloses 4.15M shares (5.3%) in Vertex (VERX)", "summary": "Morgan Stanley has filed a Schedule 13G, reporting a beneficial ownership of 4,146,241 shares of Vertex, Inc. (VERX) Class A Common Stock, which represents 5.3% of the class. The filing indicates shared voting power over 4,115,461 shares and shared dispositive power over all 4,14", "url": "https://www.stocktitan.net/sec-filings/VERX/schedule-13g-vertex-inc-passive-investment-disclosure-5-8c5c074353e4.html", "source_name": "Stock Titan", "published_at": "2026-05-12T15:09:48", "published_display": "12 May 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) grows Q1 2026 revenue and boosts EBITDA with cost plan", "summary": "Vertex (NASDAQ: VERX) reported strong Q1 2026 results with revenue of $196.6 million and increased non-GAAP Adjusted EBITDA to $44.1 million, driven by software subscriptions. Despite a GAAP net loss due to higher operating expenses, the company emphasized its non-GAAP profitabil", "url": "https://www.stocktitan.net/sec-filings/VERX/8-k-vertex-inc-reports-material-event-bcba1fd5f03f.html", "source_name": "Stock Titan", "published_at": "2026-05-11T03:09:27", "published_display": "11 May 2026 03:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Vertex, Inc. Class A \u2013 BX:VERX", "summary": "This article provides financial information for Vertex, Inc. Class A, traded on BX Swiss under the ticker VERX. It details the number of shareholders for different periods and mentions the data sources used.", "url": "https://www.tradingview.com/symbols/BX-VERX/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-05-09T09:40:10", "published_display": "09 May 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex: Navigating Through A Brave New AI World", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNU0RhS3JiczhYOGxBaUtuclM3dmhRRFVld0lHb3pLUFF4V3lQVWVxLWdGMG1TWEQ5dFhfLWg1dG4yOUxIS0N5b09TRTA5YWtFWkQycl9TVjB3bkE5OGtQdkZfeUNzSGFGTWszZ3cyQ2o1REZaSk1KQ3Bibkw3Tmg2YllRVDh2bFNJU0E4cTZOQmI?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Announces First Quarter 2026 Financial Results", "summary": "Vertex, Inc. announced strong financial results for its first quarter ended March 31, 2026, with revenue and adjusted EBITDA exceeding guidance. The company reported a 11.1% year-over-year revenue increase to $196.6 million and detailed its recent acquisition of Brinta, an AI-fir", "url": "https://www.sahmcapital.com/news/content/vertex-announces-first-quarter-2026-financial-results-2026-05-07", "source_name": "Sahm", "published_at": "2026-05-07T20:40:10", "published_display": "07 May 2026 20:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPWDdRcmJnTUNiVGhhT0JTbEFuUzBQMm1JMmdoeFMxdld2TzM2LU8zZ2U4TWY5R0NRV2ZhX3dOT0pOS1JxekZwSERNZ1B2cDNkSFBNQUtBVVdhZVd0VHkxa1dpQlo0WTVNbXh5VXBWal9jOUdjZDVOQXg1N1UwdGN5LW14Q2YxLTZxR2xlVFA2SGpvOHRVWjlpNm5VTEZHZw?oc=5", "source_name": "IndexBox", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Compared to Estimates, Vertex (VERX) Q1 Earnings: A Look at Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNdWVKU3FjSjYzODloT3N6aDA5VTRkN3F2bi1lT01DLUdDUUpaLVVrTkxnYkw5dVVuT1Jndk9majV6Z05zTjZ1RWpQYTlPQlZGS0p6T2FXYlUzREJJeEpZTWJBSm1EQ09JVjhwWFNDcnhBbno2ZGEycVRzMmdnSnhrZnZSWjVoaUJqRVZ5Nm5vejNVT3c1aTJqY0kyUWJnQUE?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex says April cost plan will save $60M-$70M a year from 2027", "summary": "Vertex (NASDAQ: VERX) announced its Q1 2026 financial results, reporting an 11.1% YoY revenue increase to $196.6 million and an 11.2% YoY ARR increase to $687.6 million. The company also introduced a Value Creation Plan, expected to generate $60-$70 million in annual cash savings", "url": "https://www.stocktitan.net/news/VERX/vertex-announces-first-quarter-2026-financial-ubllae9k1ece.html", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Germany backs access to Vertex's one-time gene therapy for blood disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxORXRLc2s1bno2ZkhZVFBiaDVXQ3dSSEZJU19xQkw5RGVMRUtGMXp1R2RFMkV0MlRsWHppNkwtQ1lTOFNndnJjYzEzVmhlSDMySHdSY0QzUmo2WWp2elBKVmVJT2p6dlBOT2ltTU5aMWNfYXRGcVJwREY3XzIwbjlSd1VwQnlpOUpKQUdTS3RQYzV3QjRFLXZ3NFhQVXhhNjY1cjlvUWF6R1dqeS1HYzgzenBxV292clhnQTBCelBB?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T11:04:39+00:00", "published_display": "06 May 2026 11:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading Systems Reacting to (VERX) Volatility", "summary": "This article analyzes Vertex Inc. Class A Common Stock (VERX), highlighting near and mid-term strong sentiment but a weak long-term outlook with elevated downside risk. It presents three AI-generated trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014tailore", "url": "https://news.stocktradersdaily.com/news_release/43/Trading_Systems_Reacting_to_VERX_Volatility_050526085002_1777985402.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-05T08:50:00", "published_display": "05 May 2026 08:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Profitability Return Tests Bullish Narratives Ahead Of Q1 2026 Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release Service: Vertex Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOY2JycGFpT0JHWXJaOFBtZFl4Z1lrSGxUMmU4VFNEVG5lMnV5Znc2RXA3a3ZCZF9nOWtwaGgzbmM0OWc2ZHgtZDFLTGdIMW8yZFZtR1lJVGZJeFVabzM1UEJmcDVuNjM4b0ptTXZDb2hwWWVaX1FNdjF0bE9GNG4wSllTUEZ5RF9nZlJTSjVlQU1uaW8xX1JRZnVhREdoSGx1MU53RXQtOEtEV0U2UG1v?oc=5", "source_name": "CRISPR Medicine News", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vanguard (NASDAQ: VERX) reports 4.84M Vertex shares, 6.22% stake", "summary": "Vanguard Portfolio Management has reported a beneficial ownership of 4,841,652 shares of Vertex Inc (NASDAQ: VERX) common stock, representing a 6.22% stake in the company as of March 31, 2026. This disclosure was made in a Schedule 13G SEC filing, indicating the holdings are mana", "url": "https://www.stocktitan.net/sec-filings/VERX/schedule-13g-vertex-inc-passive-investment-disclosure-5-221b08f9645b.html", "source_name": "Stock Titan", "published_at": "2026-04-30T05:10:13", "published_display": "30 Apr 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) announces 9% global workforce reduction plan", "summary": "Vertex, Inc. has announced a global Value Creation Plan that includes a 9% workforce reduction, impacting approximately 170 employees, to become more AI-enabled and improve operational efficiency. The company anticipates pre-tax charges of $6 million to $8 million, primarily for ", "url": "https://www.stocktitan.net/sec-filings/VERX/8-k-vertex-inc-reports-material-event-e88bcaed7559.html", "source_name": "Stock Titan", "published_at": "2026-04-28T20:39:31", "published_display": "28 Apr 2026 20:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex And Two More Stocks Possibly Priced Below Their Estimated Worth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex (VERX) Starting To Look Interesting After A 68% One Year Share Price Slide", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQUFZQT1NoazQtNGRBUjBsQzdZYm9NZHJ3ZHZoZENZWEhneGZxU0o4VWEzUloxVFNBdWZxVm53SzAzOTB0Um1ZU1pfM0NENDlDenN1S21ZcDZZb3BkQXZwd1A0RzF1MDE0T045eUJ4MG9lZlRxcXdlR3lUVkdQVjVXQmhIWkZKMHBKd0owcmJnc091WkFIYW5GLW16V3VtUjEyLUY5SQ?oc=5", "source_name": "Market source", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxORWx1NTliZE5Gbm9JQTc5eWNBTDdjUWI3UEZtenJzM3g4aHJfVDF3cEtQNkdFQUpXQ2pWNW9qTkkxVFVjaVJPS0ZkbkptSmFrT2ZDQlktRE5UZG8ycGRpSl9nZ1JtY19fY1BTeDBGbXliS1RWVVdfUVNFaXpLVjdrT2s2dW5JNi1ZcjVSQ3lfMnVnekQzWE03dHZLbW9uQ1hX?oc=5", "source_name": "CNBC", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Stock Soars as Breakthrough Kidney Drug Seeks U.S. Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOMXpEMVcwTFpSRXdHcV9lenZ4b1NFcDVfcjkxUGphdkJhN1dJa241dFR6clI1WlZqVnNCd05XelM0ZUJIRDV1R3gtSmJOSXN0eUlKZVozTHlWbWVvOF9lVnZuY3U0LU5jSy1vQUNuRmdvZTZoaWtadXc1LVhZN1VPUmZ3SW0tQzE0ZlczUHNJOWNrUmN1ZXc?oc=5", "source_name": "timothysykes.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Insider Selling and Mixed Analyst Views At Vertex (VERX) Has Changed Its Investment Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNOVpUME9YNEd6djJrVjhUcVAzZ200U3dWemVaQ2lpUXJhWTR1ek91ZERwRlpYTGpXaFl2TnVGb1p1RnAyX2k3X1Q1ZGpoNER4ZlFoaWRtbVMzTU1oamtJZHZEeE5zS2FfM1NpdGRKdmNmU2oyVE1XYUlTdElKWElBbUVJSDA4clRr?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Down 72% In Last 12 Months, Can Vertex Stock Recover With New AI Strategy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQZVk3M1o3b2xHQ0JGYTJramJ0UC1aZ3JMNE0zVWZFa2dMcGpqSHVRMjZ2Vmo4YkRQVEpWLV94RzZnUUhaUXVBQ0lPVEcyQnREMjhnOVJianpQQjd5bEFmTnFvN1JONDlJMjVQZFQ1ZnhPOXVEV0FKamx1WlpLV2hMUndXNk95MHBaVDhCa09XMVY3TldPVUtYTVZHN2NhTFZMZ05tQWJGb1ZCUjZjUlE?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Underlying Issues With The Quality Of Vertex's (NASDAQ:VERX) Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Can AI-Driven Tax Tech Competition Reshape Vertex\u2019s (VERX) Regulation-Focused Growth Narrative?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-22T09:40:54+00:00", "published_display": "22 Jul 2026 09:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. Stock 12\u2011Month Price Target Cut to $17.69, Implies 37% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQNnduZ2RQNDlGMVhDU0wtU0xrRU9yRWlYSEpnbnFPUW55NTJabExtSzM2X2haaVBGR0pxQThlYmEycXg5eWExM0JWQzEtNFRKWTRVVGZhblBxeVFudjJ4Q2NVOWlabzdhdGVmeWVhRjdkN1FyelJvaXUtbmRqZWp1YUpnZi1aTHJ1MFh2ZWlHV1Zla0RrSExmQTZ6OXhiR2xqODJSeEwxM3ZZcEdmLUxRQ3RKa3ZWUDQtTlJVVkdlQXByS0pmOFRiNzQ3NA?oc=5", "source_name": "TradingView", "published_at": "2026-07-21T22:20:12+00:00", "published_display": "21 Jul 2026 22:20", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ:VERX) Shares Gap Down - Time to Sell?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOeDlSVHROZFNUWWhQd3RFQk5zTjdfWVZkbm1hQ09JZmZCRnhmUDgzR2tnWHQ0bmZiTzJCQ2hadzdlZ0M5NVJQR2JIQy05cm5LS3E5ZmZRaTFPNlgyVFBDWGV3TURSOE9YYjF6UlpMNTJ4UUg3WGItaE5lYjRISjJBWE5YUkNHWmJMcjBkT0dtaFBaVEJGa2dFOGl4Z2JlMHhYWEE?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-21T15:55:01+00:00", "published_display": "21 Jul 2026 15:55", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Facing Uncertain Growth Path Amid AI Fears, Morgan Stanley Says", "summary": "", "url": "https://finance.yahoo.com/technology/ai/articles/vertex-facing-uncertain-growth-path-150628432.html", "source_name": "MT Newswires", "published_at": "2026-07-21T15:06:28+00:00", "published_display": "21 Jul 2026 15:06", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Correction: Morgan Stanley Downgrades Vertex to Equalweight From Overweight Adjusts PT to $15 From $19", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/correction-morgan-stanley-downgrades-vertex-102415096.html", "source_name": "MT Newswires", "published_at": "2026-07-21T10:24:15+00:00", "published_display": "21 Jul 2026 10:24", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley Downgrades Vertex to Equalweight From Overweight, Cuts Price Target to $15 From $19", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/morgan-stanley-downgrades-vertex-equalweight-102111462.html", "source_name": "MT Newswires", "published_at": "2026-07-21T10:21:11+00:00", "published_display": "21 Jul 2026 10:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma stock trades near record levels as cystic fibrosis franchise drives earnings growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNZnhfa2JWdGZ3RWR3SWlWNGpwLTVvZS02V2VkbWhuS183b2w3T2xqTlo2cTE5WEV5R0VpdHlfMWk3MEtjWU1DU05nTVlkdjdId19rbENMblUtZ3FXUFh0amd5MlozU2VyOWdabVZYdC12Y2lXU3h2VkZXRG9WUW9hQUZWendYd25qNUxxVHBRU2xldUxkQU9zMm94cjktOVhfLTN6aXA3VmRhSnJ5cWJLT2dxUVR0LThGdnJMXzQ5U3pSY3dydjFKeHlDcWpfZw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T02:41:41+00:00", "published_display": "21 Jul 2026 02:41", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal Plans", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-21T00:47:15+00:00", "published_display": "21 Jul 2026 00:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma stock trades near highs as cystic fibrosis portfolio drives double digit revenue growt", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOTzhSTHQzWjB4NmVtaXFVQnBkWmgtLVMzUjNYSVRsR3I3U1RVamZlMTFTSXg5T1JURUpOX1RBT0NPMk9qaVBNMVB3c2laSm5fLUUxZEhmOFcwYmFpR1pFTU9oR0VWdFo0cGcyc1pWbGV3LXhhYnp5UUQ4TUMxX0RzcjFfQkg2VmREN1Jfak5CMHplQU5faXFwemdKa3RpdjRoZk5ZVmtxczdWcENKcVVpcVJvRUZ6c3V1bVdfdGpBdjF2UFlMcjYzRWNqWUw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-20T14:14:50+00:00", "published_display": "20 Jul 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex schedules 5 p.m. call on Aug. 3 to discuss results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQVWY0eGdKTmFQNGNmc3hZY2xZdDlzUEdZSEhVMlpaUXBhQlQzTEJ3MUhBcDVKRHdvZGE3OExsR0h4dERCRGZRb2dpY1BNOGxVb3c5NTZQTmNJZl8wb3hNcjZ3U25kSlNVZGtmdUJfSDJVOXBLYXRLWk5XUVBSYWNfYmgxVlRsSXBZVjV3Y1RTSEc4SHBNMDNBT2pQeXdNenZ3Yl9uVzc4RzNZbk1QTUFiYmhwZFh4ZzQtVERWblVn?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:30:00+00:00", "published_display": "14 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to Announce Second Quarter 2026 Financial Results on Monday, August 3, 2026", "summary": "Vertex, Inc. (NASDAQ:VERX) announced that it will release its second quarter 2026 financial results after market close on Monday, August 3, 2026. A conference call to discuss these results will be held at 5:00 p.m. Eastern Time on the same day. Investors can register for the live", "url": "https://www.sahmcapital.com/news/content/vertex-to-announce-second-quarter-2026-financial-results-on-monday-august-3-2026-2026-07-14", "source_name": "Sahm", "published_at": "2026-07-14T12:40:53", "published_display": "14 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Vertex, Inc. Class A \u2013 LS:A2P93F", "summary": "This article focuses on the \"Enterprise value to EBIT forward\" metric for Vertex, Inc. Class A, identified by the stock symbol A2P93F on the Lang & Schwarz Tradecenter. The piece is primarily a financial data point from TradingView, indicating a specific valuation ratio for the c", "url": "https://www.tradingview.com/symbols/LS-A2P93F/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-12T11:10:47", "published_display": "12 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Vertex, Inc. Class A \u2013 LSX:A2P93F", "summary": "This article displays the enterprise value to EBIT forward for Vertex, Inc. Class A (LSX:A2P93F) on TradingView. It provides a brief financial metric for the company, accessible through the platform's various financial tools and data services.", "url": "https://www.tradingview.com/symbols/LSX-A2P93F/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T10:10:09", "published_display": "11 Jul 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Inc (VERX) Shares Fall 3.2% -- What GF Score of 61 Tells Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU0NaM0tiUm5Fbk5YVzFEcXdLaXV2bGR2R1NVb3JzR25yMm1yVTRqMkVHd2J4NTI0dXN3QmsyTmxlME1FRjl3TFJNSmhhaHhJVVFCNTZONXF5MGpTR3A0QnVKeW1PTVBzNGdFVENPd1c1Ty1VQWVMY3d6VkY0em5QSENvRVJ6S2tDc2pMRlR1SzhRci1qTXY1bnpUbGtwUnp2SXd6UFpVX0RCTzJ1d3BpdDU1S3JLajRs?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T22:58:15+00:00", "published_display": "10 Jul 2026 22:58", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Understanding Momentum Shifts in (VERX)", "summary": "This article provides an analysis of Vertex Inc. (VERX) stock, highlighting strong near and mid-term sentiment but a weak long-term outlook. It presents AI-generated trading strategies for different risk profiles, including position trading, momentum breakout, and risk hedging, a", "url": "https://news.stocktradersdaily.com/news_release/1/Understanding_Momentum_Shifts_in_VERX_071026040401_1783713841.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-10T16:04:00", "published_display": "10 Jul 2026 16:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TD Cowen Rates Vertex (VERX) A Buy; Sees Sentiment Improving On Execution", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOc0U1NEgxemRleW1SMEFIVy1KX3lmd3ZfZTJYMHBKN3ZoR0xPcHY0d3JZY2x5WGZFZmdnd2Vsak9LdEVhOVNHZVFSXzVGNFJYRkNGZ2tLdnhRTXJMaE1IRk43YkJadHBpS0E1OHRwQ2RJTm1scG5fcnV4Y0R3VUN3S3FfclMxYTJsN3hWSmtZdDF2UzBjbXc?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Vertex Stock Is Rising Today", "summary": "", "url": "https://finance.yahoo.com/m/4c378eb1-24dd-349f-ae04-0604d05f7b6c/why-vertex-stock-is-rising.html", "source_name": "Motley Fool", "published_at": "2026-06-29T16:21:15+00:00", "published_display": "29 Jun 2026 16:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TD Cowen Initiates Vertex at Buy With $14 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/td-cowen-initiates-vertex-buy-105647738.html", "source_name": "MT Newswires", "published_at": "2026-06-29T10:56:47+00:00", "published_display": "29 Jun 2026 10:56", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma enters Russell 1000 value, shares reflect mixed benchmark shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPTzV2bGgyQlphM1F0NU9ieGJrTENmWkV6UVRYTEp1djd2MHpfdFRscUxkamtMY1lHRk56VHZSRnd4Tnc1dEVTV0M0aFJpeFZXNnJhNDVVTkJ6YW5QNy1raGZUU0dxaWhWdWY5SmRwSmhNYS1ENmlmTVJZMTdydnQ4UF90QlFNaERQS25TUE9YcnktM2xLN0dDVWtQQ0lKQ1FmamxvYnlOWEhQdWtrSlNDYzU0cktiRE5Zb21HMzVKdWtGWDl2bjFrMg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-29T08:39:04+00:00", "published_display": "29 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. Class A Actuals & Estimates (NASDAQ:VERX)", "summary": "This article provides current financial data and analyst estimates for Vertex, Inc. (VERX), a company traded on NASDAQ. It covers stock performance, price targets, earnings, revenue, market capitalization, and volatility, along with answers to frequently asked questions about the", "url": "https://www.tradingview.com/symbols/NASDAQ-VERX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T13:09:42", "published_display": "26 Jun 2026 13:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Vertex, Inc. Class A \u2013 FWB:56X", "summary": "This page from TradingView provides financial information for Vertex, Inc. Class A (FWB:56X) on the Frankfurt Stock Exchange, specifically focusing on its Price to Earnings Forward metric. The content highlights the stock's overview, financials, news, and community discussions. I", "url": "https://www.tradingview.com/symbols/FWB-56X/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T00:41:37", "published_display": "26 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. Class A Actuals & Estimates (MUN:56X)", "summary": "This article provides actuals and estimates for Vertex, Inc. Class A (MUN:56X), detailing its financial performance, analyst forecasts, and key company data. It includes information on past earnings, revenue, net income, and upcoming earnings reports, along with historical stock ", "url": "https://www.tradingview.com/symbols/MUN-56X/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T23:41:37", "published_display": "25 Jun 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma Stock (US92532F1003): Analyst sentiment and ownership moves keep VRTX in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPbVZmZ1E1QlA2bS1lSXZFWVh0S0VYblN5d3FqWFpfcDZqbERuSlpYY0M1aWdfcU9OenZCb0dZT25kSHA5bXBWUkNFYno3aHRrdlNGRF9GN3pKcTRsTzZ1REdGT3ZKNEFMVHp2UUNadjUzX1ZYQmpBM252cEs2cTBZMkJsMzBLM1VMbjY0VldTd05BNnFzZlNZYVVQSWZSdjB3ZWVjOEM3NThtSTFOS2tVUUhjYXJzWllfSW9Wc2Y1WDAyOWItNGRsZg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) director Philip Saunders receives 15,638 restricted shares in equity grant", "summary": "Vertex, Inc. director Philip Seth Saunders received an equity grant of 15,638 shares of Class A Common Stock as restricted stock, with no cash purchase price. This grant increases his direct holdings to 50,606 shares. The restricted shares will vest on the earlier of the day imme", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-f969999a3bcf.html", "source_name": "Stock Titan", "published_at": "2026-06-13T12:39:12", "published_display": "13 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) director granted 15,638 restricted shares", "summary": "Vertex, Inc. director Gayton Bradley M was granted 15,638 restricted shares of Class A Common Stock at no cash cost per share, increasing his direct holdings to 68,500 shares. The restricted stock award vests on the earlier of the day before the company's next annual stockholder ", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-b1299e59442d.html", "source_name": "Stock Titan", "published_at": "2026-06-13T12:09:16", "published_display": "13 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) director granted 15,638 shares of restricted stock", "summary": "Vertex, Inc. director John Richard Stamm was granted 15,638 shares of Class A Common Stock as restricted stock, which is considered equity compensation. These shares, valued at $0.00 per share for the grant, will vest on the earlier of the day before Vertex\u2019s next annual stockhol", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-3ff8acf236f4.html", "source_name": "Stock Titan", "published_at": "2026-06-13T12:09:16", "published_display": "13 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Eric C. Andersen awarded 15,638 Vertex (VERX) restricted shares", "summary": "Vertex, Inc. director Eric C. Andersen was granted 15,638 shares of Class A common stock as restricted stock, with no cash cost. This award will vest on the earlier of the day before the next annual stockholders\u2019 meeting or June 10, 2027. Following this grant, Andersen directly h", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-affc1a87611c.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:40", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) director Westphal awarded 15,638 restricted shares", "summary": "Vertex, Inc. director and ten percent owner Amanda Westphal was awarded 15,638 restricted shares of Class A Common Stock at no purchase price. These shares will vest on the earlier of the day before the next annual stockholder meeting or June 10, 2027. Following this grant, Westp", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-48b700e1c30d.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:40", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) director granted 15,638 restricted shares, total holdings now 20,965", "summary": "Vertex, Inc. director Mark J. Mendola was granted 15,638 restricted shares of Class A Common Stock as a compensation-related award, bringing his total direct holdings to 20,965 shares. The shares were awarded at no cash cost and will vest on the earlier of the day before the comp", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-a7ce43bc6968.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:40", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) director DeStefano granted 15,638 restricted Class A shares", "summary": "Vertex, Inc. director David DeStefano was granted 15,638 Class A Common Stock shares as restricted stock, with a stated price of $0.00 per share. This award is compensation-related and will vest on the earlier of the next annual stockholders' meeting or June 10, 2027. Following t", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-6adb7bf35c2e.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:40", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VERX SEC Filings - Vertex, Inc. 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive overview of Vertex, Inc. (VERX) SEC filings, including 10-K, 10-Q, and 8-K reports, as well as insider trading forms. It highlights recent filings detailing BlackRock's stake in Vertex, credit agreement amendments for shareholder returns, a CEO ", "url": "https://www.stocktitan.net/sec-filings/VERX/page-5.html", "source_name": "Stock Titan", "published_at": "2026-06-12T18:38:40", "published_display": "12 Jun 2026 18:38", "sentiment": "positive", "sentiment_pct": 60, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VERX Stock Price, Quote & Chart | VERTEX INC - CLASS A (NASDAQ:VERX)", "summary": "This article provides an in-depth financial overview of VERTEX INC - CLASS A (NASDAQ:VERX), including its current stock price, historical performance, and key financial metrics. It highlights the company's valuation, growth, profitability, and technical and fundamental ratings. T", "url": "https://www.chartmill.com/stock/quote/VERX/profile", "source_name": "ChartMill", "published_at": "2026-06-05T21:40:11", "published_display": "05 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. (VERX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOb0FCUExTdlhQSWNGdHhHcWZ2VXBNUWgzYi1za1d4a0NsVFFwUzRpRVBoUDJxRXo5UkNvbmpRN0VMYlpWSnNWdmd1R05NbXdzWFYybEdkX2VZYVRMTEFvNnN5QUhEOFFrVDhQTG50ejZ4SGN4a1owQzhPdVhaREpPNHFNZ2paMXNoNlUyUWx6czV4SzlHSWQwTlBoc1RuQzIzTE9JVjFVRjgzaGxDNTlyeDN3b01VNUxNem05aFZZZlZNaDc4eGJj?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex director David DeStefano sells $82,365 in class A common stock.", "summary": "Vertex director David DeStefano sold 6,460 shares of Class A common stock worth $82,365 on May 28, 2026, selling at $12.75 per share, even though the stock has since risen. The shares were held indirectly through family trusts for his children. Despite this sale, Vertex Inc. rece", "url": "https://au.investing.com/news/insider-trading-news/vertex-director-david-destefano-sells-82365-in-class-a-common-stock-93CH-4465842", "source_name": "Investing.com Australia", "published_at": "2026-06-01T22:09:41", "published_display": "01 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) director\u2019s family trusts sell 6,460 shares, large stake remains", "summary": "Vertex Inc. director David DeStefano's family trusts sold 6,460 Class A Common Stock shares at $12.75 each, as reported in a Form 4 filing. Following the sale, the family trusts retained 197,572 shares, and DeStefano directly holds a substantial 1,255,517 Class A shares, indicati", "url": "https://www.stocktitan.net/sec-filings/VERX/form-4-vertex-inc-insider-trading-activity-e9512b95889c.html", "source_name": "Stock Titan", "published_at": "2026-06-01T20:40:49", "published_display": "01 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VERX) Is Up 11.3% After Brinta Deal And AI-Focused Cost Cuts Reshape Tax Strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPd0JMcnZHYVd3UC1EOUpaYjNzR0NsX3FwUEhMZTR3NFRldzNWNkZ2MDdiTXZGRkdaT1pvSElTNzJxLWNRMEh1dDQxcDRXemkxck5mMWlEQmZ6RUE0YTR3aEtaSUNBQlhNWmhUX3cySmd4ZmJFMHl5Tks4THNHdDE2cnNxQWpRamJLNmN1SnItaGtlQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals (VRTX) Offering Opportunity After Recent Pipeline Headlines And DCF Valuation Gap", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(VERX) Movement Within Algorithmic Entry Frameworks", "summary": "This article provides an algorithmic analysis of Vertex Inc. Class A Common Stock (NASDAQ: VERX), highlighting a neutral sentiment in shorter horizons but maintaining a weak long-term bias. It outlines three distinct AI-generated trading strategies\u2014Position Trading, Momentum Brea", "url": "https://news.stocktradersdaily.com/news_release/1/VERX_Movement_Within_Algorithmic_Entry_Frameworks_052726110601_1779894361.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-27T11:06:00", "published_display": "27 May 2026 11:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex, Inc. - Class A Common Stock (NQ: VERX", "summary": "This article provides a collection of recent news headlines and press releases concerning Vertex, Inc. (NASDAQ: VERX). It covers financial results announcements, tax rate reports, and various analyst and market commentary on the company's stock performance and industry position. ", "url": "https://markets.financialcontent.com/stocks/quote/news?CurrentPage=6&Symbol=NQ%3AVERX", "source_name": "FinancialContent", "published_at": "2026-05-14T13:09:52", "published_display": "14 May 2026 13:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley discloses 4.15M shares (5.3%) in Vertex (VERX)", "summary": "Morgan Stanley has filed a Schedule 13G, reporting a beneficial ownership of 4,146,241 shares of Vertex, Inc. (VERX) Class A Common Stock, which represents 5.3% of the class. The filing indicates shared voting power over 4,115,461 shares and shared dispositive power over all 4,14", "url": "https://www.stocktitan.net/sec-filings/VERX/schedule-13g-vertex-inc-passive-investment-disclosure-5-8c5c074353e4.html", "source_name": "Stock Titan", "published_at": "2026-05-12T15:09:48", "published_display": "12 May 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) grows Q1 2026 revenue and boosts EBITDA with cost plan", "summary": "Vertex (NASDAQ: VERX) reported strong Q1 2026 results with revenue of $196.6 million and increased non-GAAP Adjusted EBITDA to $44.1 million, driven by software subscriptions. Despite a GAAP net loss due to higher operating expenses, the company emphasized its non-GAAP profitabil", "url": "https://www.stocktitan.net/sec-filings/VERX/8-k-vertex-inc-reports-material-event-bcba1fd5f03f.html", "source_name": "Stock Titan", "published_at": "2026-05-11T03:09:27", "published_display": "11 May 2026 03:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Vertex, Inc. Class A \u2013 BX:VERX", "summary": "This article provides financial information for Vertex, Inc. Class A, traded on BX Swiss under the ticker VERX. It details the number of shareholders for different periods and mentions the data sources used.", "url": "https://www.tradingview.com/symbols/BX-VERX/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-05-09T09:40:10", "published_display": "09 May 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex: Navigating Through A Brave New AI World", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNU0RhS3JiczhYOGxBaUtuclM3dmhRRFVld0lHb3pLUFF4V3lQVWVxLWdGMG1TWEQ5dFhfLWg1dG4yOUxIS0N5b09TRTA5YWtFWkQycl9TVjB3bkE5OGtQdkZfeUNzSGFGTWszZ3cyQ2o1REZaSk1KQ3Bibkw3Tmg2YllRVDh2bFNJU0E4cTZOQmI?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Announces First Quarter 2026 Financial Results", "summary": "Vertex, Inc. announced strong financial results for its first quarter ended March 31, 2026, with revenue and adjusted EBITDA exceeding guidance. The company reported a 11.1% year-over-year revenue increase to $196.6 million and detailed its recent acquisition of Brinta, an AI-fir", "url": "https://www.sahmcapital.com/news/content/vertex-announces-first-quarter-2026-financial-results-2026-05-07", "source_name": "Sahm", "published_at": "2026-05-07T20:40:10", "published_display": "07 May 2026 20:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPWDdRcmJnTUNiVGhhT0JTbEFuUzBQMm1JMmdoeFMxdld2TzM2LU8zZ2U4TWY5R0NRV2ZhX3dOT0pOS1JxekZwSERNZ1B2cDNkSFBNQUtBVVdhZVd0VHkxa1dpQlo0WTVNbXh5VXBWal9jOUdjZDVOQXg1N1UwdGN5LW14Q2YxLTZxR2xlVFA2SGpvOHRVWjlpNm5VTEZHZw?oc=5", "source_name": "IndexBox", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Compared to Estimates, Vertex (VERX) Q1 Earnings: A Look at Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNdWVKU3FjSjYzODloT3N6aDA5VTRkN3F2bi1lT01DLUdDUUpaLVVrTkxnYkw5dVVuT1Jndk9majV6Z05zTjZ1RWpQYTlPQlZGS0p6T2FXYlUzREJJeEpZTWJBSm1EQ09JVjhwWFNDcnhBbno2ZGEycVRzMmdnSnhrZnZSWjVoaUJqRVZ5Nm5vejNVT3c1aTJqY0kyUWJnQUE?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex says April cost plan will save $60M-$70M a year from 2027", "summary": "Vertex (NASDAQ: VERX) announced its Q1 2026 financial results, reporting an 11.1% YoY revenue increase to $196.6 million and an 11.2% YoY ARR increase to $687.6 million. The company also introduced a Value Creation Plan, expected to generate $60-$70 million in annual cash savings", "url": "https://www.stocktitan.net/news/VERX/vertex-announces-first-quarter-2026-financial-ubllae9k1ece.html", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Germany backs access to Vertex's one-time gene therapy for blood disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxORXRLc2s1bno2ZkhZVFBiaDVXQ3dSSEZJU19xQkw5RGVMRUtGMXp1R2RFMkV0MlRsWHppNkwtQ1lTOFNndnJjYzEzVmhlSDMySHdSY0QzUmo2WWp2elBKVmVJT2p6dlBOT2ltTU5aMWNfYXRGcVJwREY3XzIwbjlSd1VwQnlpOUpKQUdTS3RQYzV3QjRFLXZ3NFhQVXhhNjY1cjlvUWF6R1dqeS1HYzgzenBxV292clhnQTBCelBB?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T11:04:39+00:00", "published_display": "06 May 2026 11:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading Systems Reacting to (VERX) Volatility", "summary": "This article analyzes Vertex Inc. Class A Common Stock (VERX), highlighting near and mid-term strong sentiment but a weak long-term outlook with elevated downside risk. It presents three AI-generated trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014tailore", "url": "https://news.stocktradersdaily.com/news_release/43/Trading_Systems_Reacting_to_VERX_Volatility_050526085002_1777985402.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-05T08:50:00", "published_display": "05 May 2026 08:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Profitability Return Tests Bullish Narratives Ahead Of Q1 2026 Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release Service: Vertex Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOY2JycGFpT0JHWXJaOFBtZFl4Z1lrSGxUMmU4VFNEVG5lMnV5Znc2RXA3a3ZCZF9nOWtwaGgzbmM0OWc2ZHgtZDFLTGdIMW8yZFZtR1lJVGZJeFVabzM1UEJmcDVuNjM4b0ptTXZDb2hwWWVaX1FNdjF0bE9GNG4wSllTUEZ5RF9nZlJTSjVlQU1uaW8xX1JRZnVhREdoSGx1MU53RXQtOEtEV0U2UG1v?oc=5", "source_name": "CRISPR Medicine News", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vanguard (NASDAQ: VERX) reports 4.84M Vertex shares, 6.22% stake", "summary": "Vanguard Portfolio Management has reported a beneficial ownership of 4,841,652 shares of Vertex Inc (NASDAQ: VERX) common stock, representing a 6.22% stake in the company as of March 31, 2026. This disclosure was made in a Schedule 13G SEC filing, indicating the holdings are mana", "url": "https://www.stocktitan.net/sec-filings/VERX/schedule-13g-vertex-inc-passive-investment-disclosure-5-221b08f9645b.html", "source_name": "Stock Titan", "published_at": "2026-04-30T05:10:13", "published_display": "30 Apr 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (NASDAQ: VERX) announces 9% global workforce reduction plan", "summary": "Vertex, Inc. has announced a global Value Creation Plan that includes a 9% workforce reduction, impacting approximately 170 employees, to become more AI-enabled and improve operational efficiency. The company anticipates pre-tax charges of $6 million to $8 million, primarily for ", "url": "https://www.stocktitan.net/sec-filings/VERX/8-k-vertex-inc-reports-material-event-e88bcaed7559.html", "source_name": "Stock Titan", "published_at": "2026-04-28T20:39:31", "published_display": "28 Apr 2026 20:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex And Two More Stocks Possibly Priced Below Their Estimated Worth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex (VERX) Starting To Look Interesting After A 68% One Year Share Price Slide", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQUFZQT1NoazQtNGRBUjBsQzdZYm9NZHJ3ZHZoZENZWEhneGZxU0o4VWEzUloxVFNBdWZxVm53SzAzOTB0Um1ZU1pfM0NENDlDenN1S21ZcDZZb3BkQXZwd1A0RzF1MDE0T045eUJ4MG9lZlRxcXdlR3lUVkdQVjVXQmhIWkZKMHBKd0owcmJnc091WkFIYW5GLW16V3VtUjEyLUY5SQ?oc=5", "source_name": "Market source", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxORWx1NTliZE5Gbm9JQTc5eWNBTDdjUWI3UEZtenJzM3g4aHJfVDF3cEtQNkdFQUpXQ2pWNW9qTkkxVFVjaVJPS0ZkbkptSmFrT2ZDQlktRE5UZG8ycGRpSl9nZ1JtY19fY1BTeDBGbXliS1RWVVdfUVNFaXpLVjdrT2s2dW5JNi1ZcjVSQ3lfMnVnekQzWE03dHZLbW9uQ1hX?oc=5", "source_name": "CNBC", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Stock Soars as Breakthrough Kidney Drug Seeks U.S. Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOMXpEMVcwTFpSRXdHcV9lenZ4b1NFcDVfcjkxUGphdkJhN1dJa241dFR6clI1WlZqVnNCd05XelM0ZUJIRDV1R3gtSmJOSXN0eUlKZVozTHlWbWVvOF9lVnZuY3U0LU5jSy1vQUNuRmdvZTZoaWtadXc1LVhZN1VPUmZ3SW0tQzE0ZlczUHNJOWNrUmN1ZXc?oc=5", "source_name": "timothysykes.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Insider Selling and Mixed Analyst Views At Vertex (VERX) Has Changed Its Investment Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNOVpUME9YNEd6djJrVjhUcVAzZ200U3dWemVaQ2lpUXJhWTR1ek91ZERwRlpYTGpXaFl2TnVGb1p1RnAyX2k3X1Q1ZGpoNER4ZlFoaWRtbVMzTU1oamtJZHZEeE5zS2FfM1NpdGRKdmNmU2oyVE1XYUlTdElKWElBbUVJSDA4clRr?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Down 72% In Last 12 Months, Can Vertex Stock Recover With New AI Strategy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQZVk3M1o3b2xHQ0JGYTJramJ0UC1aZ3JMNE0zVWZFa2dMcGpqSHVRMjZ2Vmo4YkRQVEpWLV94RzZnUUhaUXVBQ0lPVEcyQnREMjhnOVJianpQQjd5bEFmTnFvN1JONDlJMjVQZFQ1ZnhPOXVEV0FKamx1WlpLV2hMUndXNk95MHBaVDhCa09XMVY3TldPVUtYTVZHN2NhTFZMZ05tQWJGb1ZCUjZjUlE?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Underlying Issues With The Quality Of Vertex's (NASDAQ:VERX) Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 114, "total_relevant": 65, "sentiment_summary": {"positive": 16, "negative": 8, "neutral": 41, "score": 52, "total": 65, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 16.45, "count": 28}, {"event": "earnings", "label": "Earnings", "weight": 9.35, "count": 17}, {"event": "deals", "label": "Deals and strategy", "weight": 3.3, "count": 6}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.2, "count": 4}, {"event": "guidance", "label": "Guidance", "weight": 1.65, "count": 3}], "positive_events": 16, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 12.8, "latest_week": "2026-07-17", "one_week_move": 3.4, "four_week_move": 15.1, "twelve_week_move": 2.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.922757, "market_dynamics_buy_signal": false, "relative_strength": -38.56488, "fair_value_gap": -56.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.2555, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.4% over one week, +15.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 59, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 16}, {"label": "TradingView", "count": 7}, {"label": "simplywall.st", "count": 6}, {"label": "Market source", "count": 5}, {"label": "MT Newswires", "count": 4}, {"label": "Ad-hoc-news.de", "count": 4}, {"label": "Stock Traders Daily", "count": 3}, {"label": "Sahm", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 65}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 28}, {"label": "Earnings", "count": 17}, {"label": "Deals and strategy", "count": 6}, {"label": "Analyst action", "count": 5}, {"label": "Balance sheet", "count": 4}, {"label": "Guidance", "count": 3}, {"label": "Macro sensitivity", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "65", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.4% over one week, +15.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Can AI-Driven Tax Tech Competition Reshape Vertex\u2019s (VERX) Regulation-Focused Growth Narrative?"}], "updated_at": "2026-07-22T10:20:42.531674+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}